Skip to main content

Table 3 Bacteria associated with ventilator-associated tracheobronchitis episodes

From: Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study

Ā 

Intention to treat

Modified intention to treat

Ā 

Antibiotic treatment

n = 22

No antibiotic treatment

n = 36

Antibiotic treatment

n = 18

No antibiotic treatment

n = 26

Microorganisms, number

27

39

22

29

Polymicrobial VAT

5 (22)

3 (8)

4 (22)

3 (11)

MDR bacteria

10 (45)

17 (47)

9 (50)

14 (53)

Gram-negative

20 (90)

27 (75)

16 (88)

20 (76)

ā€ƒā€ƒā€ƒPseudomonas aeruginosa

8 (36)

11 (30)

7 (31)

9 (34)

ā€ƒā€ƒā€ƒEnterobacter species

2 (9)

3 (8)

2 (11)

3 (11)

ā€ƒā€ƒā€ƒEscherichia coli

3 (13)

3 (8)

1 (5)

2 (7)

ā€ƒā€ƒā€ƒProteus mirabilis

3 (13)

1 (2)

2 (11)

1 (3)

ā€ƒā€ƒā€ƒCitrobacter freundii

1 (4)

2 (5)

1 (5)

1 (3)

ā€ƒā€ƒā€ƒAcinetobacter baumannii

0 (0)

2 (5)

0 (0)

2 (7)

ā€ƒā€ƒā€ƒMorganella morgani

1 (4)

2 (5)

1 (5)

1 (3)

ā€ƒā€ƒā€ƒHemophilus influenzae

0 (0)

1 (2)

0 (0)

1 (3)

ā€ƒā€ƒā€ƒStenotrophomonas maltophilia

1 (4)

1 (2)

1 (5)

0 (0)

ā€ƒā€ƒā€ƒKlebsiella oxytoca

1 (4)

1 (2)

1 (5)

0 (0)

Gram-positive

7 (31)

12 (33)

6 (33)

9 (34)

ā€ƒā€ƒā€ƒMethicillin-resistant Staphylococcus aureus

3 (13)

6 (16)

3 (16)

5 (19)

ā€ƒā€ƒā€ƒMethicillin-sensitive S. aureus

3 (13)

4 (11)

2 (11)

4 (15)

ā€ƒā€ƒā€ƒStreptococcus pneumoniae

1 (4)

2 (5)

1 (5)

0 (0)

  1. P > 0.2 for all comparisons (antibiotic versus no antibiotic treatment). Results are presented as number (percentage) unless otherwise indicated. MDR, multidrug-resistant; VAT, ventilator-associated tracheobronchitis.